NCT02985840View on ClinicalTrials.gov

Ondansetron Versus Dexamethasone/Ondansetron to Treat Acute Nausea in the Emergency Department

PHASE4TerminatedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

January 28, 2014

Primary Completion Date

November 15, 2016

Study Completion Date

November 15, 2016

Conditions
NauseaAbdominal Pain
Interventions
DRUG

Ondansetron

Patients receive intravenous ondansetron (4mg) followed by two 5ml normal saline flushes

DRUG

Dexamethasone

Patients receive intravenous ondansetron(4mg) followed by intravenous dexamethasone (4mg), followed by a single 5ml normal saline flush

Trial Locations (1)

43228

OhioHealth Doctors Hospital, Columbus

Sponsors

Lead Sponsor

OhioHealth
All Listed Sponsors
lead

OhioHealth

OTHER

NCT02985840 - Ondansetron Versus Dexamethasone/Ondansetron to Treat Acute Nausea in the Emergency Department | Biotech Hunter | Biotech Hunter